Mirae Asset Global Etfs Holdings Ltd. Cv Rx, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Cv Rx, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 8,389 shares of CVRX stock, worth $73,319. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,389
Previous 8,779
4.44%
Holding current value
$73,319
Previous $107,000
54.21%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CVRX
# of Institutions
94Shares Held
14.9MCall Options Held
42.2KPut Options Held
32.4K-
Johnson & Johnson New Brunswick, NJ4.1MShares$35.9 Million8.12% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$17.7 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.08MShares$9.42 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$7.65 Million0.0% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT789KShares$6.9 Million0.62% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $180M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...